Market Research Logo

North America Diabetes Care Devices Market to 2027 - Regional Analysis and Forecasts by Product (Glucose Monitoring Devices and Insulin Delivery Devices); End User (Homecare and Hospitals & Clinics); and Country

North America Diabetes Care Devices Market to 2027 - Regional Analysis and Forecasts by Product (Glucose Monitoring Devices and Insulin Delivery Devices); End User (Homecare and Hospitals & Clinics); and Country

The North America diabetes care devices market is expected to reach US$ 15,300.0 Mn in 2027 from US$ 8,936.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.

The growth of the diabetes care devices market is primarily attributed to the growing geriatric population and rapid technological advancements in diabetes care devices. However, high cost of diabetes care devices and risks associated with the insulin delivery devices are likely to pose a negative impact on the market growth. On the other hand, development of cost efficient pen needles is likely to have a positive impact on the growth of the North America diabetes care devices market in the coming years.

The advancement in the field of the healthcare industry is driving to the players for more research and developments for insulin delivery devices. There are many methods to deliver insulin into the body such as needles, insulin pens and insulin pumps. Insulin pumps are small computerized diabetes management devises, connected with cannula under the skin that is used to deliver a slow continuous level of insulin. The program can be controlled by the individual depends on the more or less requirement. The increasing advancements and technology in glucose monitoring devices have result into smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose (BG) meter and insulin delivery devices has been also improved. The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices. For instance, in September 2016, the FDA announced their first automatically automatic glucose monitoring device, Medtronic’s MiniMed 670G which is a hybrid closed looped system that provide suitable insulin doses in patient of age 14 years and above with diabetes type 1. Pen needles and syringes are the most commonly used device for injecting insulin to the diabetic patients. In addition, to reduce the injection site repetition for drug administration, montméd Inc. in April 2017 introduced a new a variant of SiteSmart colored pen needles to keep the injection site tissue healthy and promote better insulin adoption. Thus, the technological advancements coupled with increasing influx of new products into the market is expected to propel the growth of global pen needles market over the forecast years.

In 2018, the glucose monitoring devices segment held a largest market share of 54.2% of the diabetes care devices market, by product. The glucose monitoring devices is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes and presence of the several market players that offers technically advanced products. The testing strips segment among the glucose monitoring devices is anticipated to witness the fastest growth rate of 7.2% during the forecast period, 2019 to 2027 owing to the enormous usages in the glucose monitoring devices.

Homecare held a largest market share of 59.9% of the diabetes care devices market, by end user in 2018. This segment is also expected to dominate the market in 2027 owing to the rise in the demand for the glucose monitoring devices and insulin delivery devices. Increasing diabetic population, the ease of use, availability, and accessibility of insulin delivery devices has also increased the adoption of self-administration among patients is anticipated to grow at a steady rate during the forecast period. Also the homecare segment is also expected to grow at the fastest growth rate of 6.6% during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for diabetes care devices included in the report are, Associação de Diabetes Juvenil (ADJ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), International Diabetes Federation(IDF) National Institute for Health and Care Excellence (NICE) and others.


Part 1.Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
Part 2.North America Diabetes Care Devices Market – Key Takeaways
Part 3.North America Diabetes Care Devices Market – Market Landscape
3.1 overview
3.2 market segmentation
3.2.1 North America Diabetes Care Devices Market – By Product
3.2.2 North America Diabetes Care Devices Market – By End USer
3.2.3 North America Diabetes Care Devices Market – By Country
3.3 PEST Analysis
Part 4.North America Diabetes Care Devices Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Geriatric Population
4.1.2 Rapid Technological Advancements in Diabetes Care Devices
4.2 Key Market Restraints
4.2.1 High Cost of Diabetes Care Devices
4.2.2 Risks Associated with the Insulin Delivery Devices
4.3 Key Market Opportunities
4.3.1 Development of Cost Efficient Pen Needles
4.4 future Trends
4.4.1 Growing Product Innovations
4.5 Impact analysis
Part 5.Diabetes Care Devices Market – North America Analysis
5.1 North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 Medtronic
5.3.2 F. Hoffmann-La Roche Ltd.
Part 6.North America Diabetes Care Devices Market Analysis – By Product
6.1 overview
6.2 North America diabetes care devices Market BY Product, 2018 & 2027 (%)
6.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.4 Glucose Monitoring Devices Market
6.4.1 Overview
6.4.2 North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.4.3 Glucometers Market
6.4.3.1 Overview
6.4.3.2 North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Lancets Market
6.4.4.1 Overview
6.4.4.2 North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Testing Strips Market
6.4.5.1 Overview
6.4.5.2 North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)
6.4.6 Other Glucose Monitoring Devices Market
6.4.6.1 Overview
6.4.6.2 North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Insulin Delivery Devices Market
6.5.1 Overview
6.5.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Insulin Pens Market
6.5.3.1 Overview
6.5.3.2 North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Insulin Syringes Market
6.5.4.1 Overview
6.5.4.2 North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Insulin Pumps Market
6.5.5.1 Overview
6.5.5.2 North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Other Insulin Delivery Devices Market
6.5.6.1 Overview
6.5.6.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
Part 7.North America Diabetes Care Devices Market Analysis – By End USer
7.1 Overview
7.2 NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End USer, 2018 & 2027 (%)
7.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
7.4 Homecare Market
7.4.1 Overview
7.4.2 North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 hospitals & Clinics Market
7.5.1 Overview
7.5.2 North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Part 8.North America Diabetes Care Devices Market Revenue And Forecasts To 2027
8.1 Overview
8.2 North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.5 North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)
8.6 US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
8.6.1 US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.2.1 US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.2.2 US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.3 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.7 Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.1 Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.2.1 Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.2.2 Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.3 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
8.8 Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.1 Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.2.1 Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.2.2 Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.3 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
Part 9.Diabetes Care Devices Market – Industry Landscape
9.1 Overview
9.2 Comparative Company Analysis
9.3 Growth Strategies done by the companies in the Market, (%)
9.4 Organic Developments
9.4.1 Overview
9.5 Inorganic developments
9.5.1 Overview
Part 10.Diabetes Care Devices Market–Key Company Profiles
10.1 BD
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 novo nordisk a/s
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 B. Braun Melsungen AG
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Medtronic
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Tandem Diabetes Care, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Insulet Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Information
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Eli lilly and company
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Dexcom, Inc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Terumo Corporation
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product portfolio
10.9.5 SWOT ANALYSIS
10.9.6 KEY DEVELOPMENTS
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
Part 11.Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
LIST OF TABLES
TABLE 1. TOTAL NUMBER OF PERSONS OFAGED 60 YEARS OR ABOVE BY REGION, 2017 & 2050
TABLE 2. NORTH AMERICA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 3. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 4. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 5. NORTH AMERICA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 6. NORTH AMERICA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 7. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 8. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 9. NORTH AMERICA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 10. US DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 11. US GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 12. US INSULIN DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 13. US DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 14. CANADA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 15. CANADA GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 16. CANADA INSULIN DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 17. CANADA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 18. MEXICO DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 19. MEXICO GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 20. MEXICO INSULIN DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 21. MEXICO DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 22. ORGANIC DEVELOPMENTS DONE BY COMPANIES
TABLE 23. INORGANIC DEVELOPMENTS DONE BY COMPANIES
TABLE 24. GLOSSARY OF TERMS, DIABETES CARE DEVICES MARKET
LIST OF FIGURES
FIGURE 1. US DIABETES CARE DEVICES MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2027 19
FIGURE 2. NORTH AMERICA DIABETES CARE DEVICES MARKET BY PRODUCT, MARKET SHARE (%), 2018 20
FIGURE 3. NORTH AMERICA DIABETES CARE DEVICES MARKET BY END USER, MARKET SHARE (%), 2018 21
FIGURE 4. DIABETES CARE DEVICES MARKET SEGMENTATION 23
FIGURE 5. NORTH AMERICA PEST ANALYSIS 25
FIGURE 6. DIABETES CARE DEVICES MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS 33
FIGURE 7. NORTH AMERICA DIABETES CARE DEVICES MARKET - REVENUE FORECASTS AND ANALYSIS - 2018- 2027 35
FIGURE 8. NORTH AMERICA DIABETES CARE DEVICES MARKET, BY PRODUCT 2018 & 2027 (%) 38
FIGURE 9. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 42
FIGURE 10. NORTH AMERICA GLUCOMETERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 44
FIGURE 11. NORTH AMERICA LANCETS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 46
FIGURE 12. NORTH AMERICA TESTING STRIPS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 48
FIGURE 13. NORTH AMERICA OTHER GLUCOSE MONITORING DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 50
FIGURE 14. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 52
FIGURE 15. NORTH AMERICA INSULIN PENS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 54
FIGURE 16. NORTH AMERICA INSULIN SYRINGES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 56
FIGURE 17. NORTH AMERICA INSULIN PUMPS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 58
FIGURE 18. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 60
FIGURE 19. NORTH AMERICA DIABETES CARE DEVICES MARKET BY END USER, 2018 & 2027 (%) 61
FIGURE 20. NORTH AMERICA HOMECARE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 64
FIGURE 21. NORTH AMERICA HOSPITALS & CLINICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 66
FIGURE 22. NORTH AMERICA DIABETES CARE DEVICES MARKET REVENUE OVERVIEW, BY COUNTRY, 2018 (US$ MN) 68
FIGURE 23. NORTH AMERICA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 69
FIGURE 24. NORTH AMERICA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 72
FIGURE 25. US DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 74
FIGURE 26. CANADA DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 78
FIGURE 27. MEXICO DIABETES CARE DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 82
FIGURE 28. COMPARATIVE COMPANY ANALYSIS 85
FIGURE 29. GROWTH STRATEGIES DONE BY THE COMPANIES IN THE MARKET, (%) 86

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook